comparemela.com
Home
Live Updates
Markusp Schlaich - Breaking News
Pages:
Markusp Schlaich News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Fluid retention and heart failure in the PRECISION trial
Fluid retention and heart failure in the PRECISION trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Markusp schlaich
Eli lilly
Nephrol hypertens
Travere pharmaceuticals
Elsevier ltd
Boehringer ingelheim
Opin nephrol hypertens
Travere therapeutics
Chinook therapeutics
Resistant Hypertension Effectively Treated With Novel Drug
Dual endothelin antagonist aprocitentan may treat resistant hypertension, high blood pressure despite use of 3 antihypertensive drugs.
United states
Western australia
United kingdom
Max delbr
Markusp schlaich
Ralf dechend
Christian delles
Dellesc endothelin
Royal perth hospital research foundation
Idorsia pharmaceuticals
Dobney hypertension centre
University of glasgow
University of western australia
North america
Molecular medicine
Resistant Hypertension Effectively Treated With Novel Drug
Dual endothelin antagonist aprocitentan may treat resistant hypertension, high blood pressure despite use of 3 antihypertensive drugs.
United states
Western australia
United kingdom
Max delbr
Ralf dechend
Markusp schlaich
Christian delles
Royal perth hospital research foundation
Idorsia pharmaceuticals
Dobney hypertension centre
University of glasgow
University of western australia
North america
Molecular medicine
vimarsana © 2020. All Rights Reserved.